The vaccine tracker: how NZ's rollout is progressing. By Andy Fyers
The company thinks a series B valuation of $140 million will make it an attractive target for a SPAC listing onto the Nasdaq.
The privacy commissioner issues first notices under new Privacy Act powers.
© Content Ltd 2021.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details